Millendo Therapeutics, Inc
(60040X103)
ファンドの報告 Millendo Therapeutics, Inc 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Great Point Partners LLC | 1,288,093 | $14,891,000k | Jun 30, 2019 | Aug 14, 2019 | |
| Frazier Management LLC | 1,396,615 | $16,145k | Jun 30, 2019 | Aug 14, 2019 | |
| Adams Street Partners LLC | 409,146 | $4,730k | Jun 30, 2019 | Aug 14, 2019 | |
| AWM Investment Company Inc | 77,629 | $897k | Jun 30, 2019 | Aug 8, 2019 | |
| Point72 Asset Management LP | 75,670 | $875k | Jun 30, 2019 | Aug 14, 2019 | |
| Prosight Management LP | 73,868 | $854k | Jun 30, 2019 | Aug 14, 2019 | |
| GMT Capital Corp | 53,419 | $618k | Jun 30, 2019 | Aug 14, 2019 |